Two Sigma Investments’s Apogee Therapeutics APGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$23.7M Buy
281,386
+176,145
+167% +$12.8M 0.02% 852
2025
Q4
$7.94M Sell
105,241
-17,134
-14% -$1.08M 0.01% 1288
2025
Q3
$4.86M Buy
122,375
+6,681
+6% +$255K 0.01% 1484
2025
Q2
$5.02M Sell
115,694
-136,441
-54% -$5.19M 0.01% 1233
2025
Q1
$9.42M Sell
252,135
-14,347
-5% -$555K 0.02% 792
2024
Q4
$12.1M Buy
266,482
+67,174
+34% +$3.43M 0.03% 669
2024
Q3
$11.7M Sell
199,308
-102,914
-34% -$4.93M 0.03% 689
2024
Q2
$11.9M Buy
302,222
+212,742
+238% +$10.3M 0.03% 647
2024
Q1
$5.95M Buy
89,480
+64,441
+257% +$2.81M 0.01% 890
2023
Q4
$700K Buy
+25,039
New +$502K ﹤0.01% 2285

Other funds holding APGE